Myogenic Vasoconstriction Requires Canonical G q/11 Signaling of the Angiotensin II Type 1 Receptor
Open Access
- 15 February 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (4)
Abstract
Background: Blood pressure and tissue perfusion are controlled in part by the level of intrinsic (myogenic) arterial tone. However, many of the molecular determinants of this response are unknown. We previously found that mice with targeted disruption of the gene encoding the angiotensin II type 1a receptor (AT1AR) ( Agtr1a ), the major murine angiotensin II type 1 receptor (AT1R) isoform, showed reduced myogenic tone; however, uncontrolled genetic events (in this case, gene ablation) can lead to phenotypes that are difficult or impossible to interpret. Methods and Results: We tested the mechanosensitive function of AT1R using tamoxifen‐inducible smooth muscle‐specific AT1aR knockout (smooth muscle‐ Agtr1a −/− ) mice and studied downstream signaling cascades mediated by G q/11 and/or β‐arrestins. FR900359, Sar1Ile4Ile8‐angiotensin II (SII), TRV120027 and TRV120055 were used as selective G q/11 inhibitor and biased agonists to activate noncanonical β‐arrestin and canonical G q/11 signaling of the AT1R, respectively. Myogenic and Ang II‐induced constrictions were diminished in the perfused renal vasculature, mesenteric and cerebral arteries of smooth muscle‐ Agtr1a −/− mice. Similar effects were observed in arteries of global mutant Agtr1a −/− but not Agtr1b −/− mice. FR900359 decreased myogenic tone and angiotensin II‐induced constrictions whereas selective biased targeting of AT1R‐β‐arrestin signaling pathways had no effects. Conclusions: This study demonstrates that myogenic arterial constriction requires G q/11 ‐dependent signaling pathways of mechanoactivated AT1R but not G protein‐independent, noncanonical pathways in smooth muscle cells.Keywords
This publication has 55 references indexed in Scilit:
- Emerging role of G protein-coupled receptors in microvascular myogenic toneCardiovascular Research, 2012
- Cardiorenal Actions of TRV120027, a Novel ß-Arrestin–Biased Ligand at the Angiotensin II Type I Receptor, in Healthy and Heart Failure CaninesCirculation: Heart Failure, 2011
- The β-Arrestin Pathway-selective Type 1A Angiotensin Receptor (AT1A) Agonist [Sar1,Ile4,Ile8]Angiotensin II Regulates a Robust G Protein-independent Signaling NetworkJournal of Biological Chemistry, 2011
- Angiotensin II Type 1A Receptors in Vascular Smooth Muscle Cells Do Not Influence Aortic Remodeling in HypertensionHypertension, 2011
- β-Arrestin–Biased Agonism of the Angiotensin Receptor Induced by Mechanical StressScience Signaling, 2010
- Gq‐coupled receptors as mechanosensors mediating myogenic vasoconstrictionThe EMBO Journal, 2008
- Modifier Locus on Mouse Chromosome 3 for Renal Vascular Pathology in AT 1A Receptor-DeficiencyHypertension, 2004
- Increased peripheral resistance in heart failure: new evidence suggests an alteration in vascular smooth muscle functionBritish Journal of Pharmacology, 2003
- Middle Cerebral Artery Function After StrokeStroke, 2002
- A novel angiotensin receptor subtype in rat mesangium. Coupling to adenylyl cyclase.Hypertension, 1993